Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers

Molecular Imaging and Biology

Volumn 13, Issue 1, 2011, Pages 172-177

  Hoshikawa, Hiroshi ^a   Nishiyama, Yoshihiro ^b   Kishino, Takehito ^a   Yamamoto, Yuka ^b   Haba, Reiji ^a   Mori, Nozomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

FDG; FLT; Head and neck squamous cell cancer; Ki 67; PET

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY;

EID: 79551607425     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0331-z     Document Type: Article

References (26)

1. EM Rohren TG Turkington RE Coleman 2004 Clinical applications of PET in oncology Radiology 231 305 332 10.1148/radiol.2312021185 15044750
2. C Laubenbacher D Saumweber C Wagner-Manslau, et al. 1995 Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas J Nucl Med 36 1747 1757 1:STN:280: DyaK28%2FgslKhsw%3D%3D 7562038
3. BM Klabbers AA Lammertsma BJ Slotman 2003 The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer Mol Imaging Biol 5 257 270 10.1016/S1536-1632(03)00102-1 14499141
4. KM Greven DW Williams 3rd WF McGuirt Sr, et al. 2001 Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 942 946 1:STN:280:DC%2BD38%2FgtVamuw%3D%3D 10.1002/hed.1136 11754497
5. LG Strauss 1996 Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients Eue J Nucl Med 2 1409 1415 10.1007/BF01367602
6. K Kubota 2001 From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology Ann Nucl Med 15 471 486 1:STN:280:DC%2BD387gtVGgsw%3D%3D 10.1007/BF02988499 11831394
7. B Ac HH Schirrmeister CA Guhlmann, et al. 2001 Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med 42 721 725
8. AF Shields SM Larson Z Grunbaum MM Graham 1984 Short-term thymidine uptake in normal and neoplastic tissues: studies for PET J Nucl Med 25 759 764 1:STN:280:DyaL2c3kt1Sisw%3D%3D 6610731
9. JS Rasey JR Grierson LW Wiens PD Kolb JC Schwartz 2002 Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells J Nucl Med 43 1210 1217 1:CAS:528:DC%2BD38Xns1elsrk%3D 12215561
10. DL Francis A Freeman D Visvikis, et al. 2003 In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography Gut 52 1602 1606 1:STN:280:DC%2BD3sritVGktg%3D%3D 10.1136/gut.52.11.1602 14570730
11. 18F-FDG PET in esophageal cancer J Nucl Med 46 400 404 15750150
12. 18F] fluorothymidine for imaging of primary breast cancer: a pilot study Eur J Nucl Med Mol Imaging 31 720 724 10.1007/s00259-004-1462-8 14991243
13. 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 1610 1616 1:CAS:528:DC%2BD2sXhtVOit7bF 10.1007/s00259-007-0449-7 17530250
14. 18F-FDG PET J Nucl Med 45 226 231 14960640
15. 18F-FDG in primary head and neck cancer correlates with survival Nuklearmedizin 47 80 85 1:STN:280: DC%2BD1cvhtFyntg%3D%3D 18392317
16. Sobin LH, Wittekind Ch (eds) (1997) UICC: TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York
17. HJ Machulla A Blocher M Kuntzsch JR Grierson 2000 Simplified labeling approach for synthesizing 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) J Radioanal Nucl Ch 24 843 846 10.1023/A:1010684101509
18. H Minn M Lapela PJ Klemi, et al. 1997 Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer J Nucl Med 38 1907 1911 1:STN:280:DyaK1c%2FptVegsA%3D%3D 9430467
19. 18F-FDG) in head and neck cancer J Laryngol Otol 113 548 554 1:STN:280:DC%2BD3c%2FntlGiuw%3D%3D 10.1017/S0022215100144457 10605586
20. R Kameyama Y Yamamoto K Izuishi, et al. 2009 Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET Eur J Nucl Med Mol Imaging 36 382 388 10.1007/s00259-008-0970-3 18985344
21. H Barthel MC Cleij DR Collingridge, et al. 2003 3′-deoxy-3′- [18F] fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 3791 3798 1:CAS:528:DC%2BD3sXltVGqs78%3D 12839975
22. S Apisarnthanarax MM Alauddin F Mourtada, et al. 2006 Early detection of chemoradioresponse in esophageal carcinoma by 3′-deoxy-3′-3H- fluorothymidine using preclinical tumor models Clin Cancer Res 12 4590 4597 1:CAS:528:DC%2BD28XnvVGks74%3D 10.1158/1078-0432.CCR-05-2720 16899606
23. EG Troost WV Vogel MA Merkx, et al. 2007 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients J Nucl Med 48 726 735 10.2967/jnumed.106.037473 17475960
24. BS Pio CK Park R Pietras, et al. 2006 Usefulness of 3′-[F-18] fluoro-3′-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy Mol Imaging Biol 8 36 42 10.1007/s11307-005- 0029-9 16362149
25. K Herrmann HA Wieder AK Buck, et al. 2007 Early response assessment using 3′-deoxy-3′-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma Clin Clin Cancer Res 13 3552 3558 1:CAS:528:DC%2BD2sXmsFCqtbo%3D 10.1158/1078-0432.CCR-06-3025
26. YJ Yang JS Ryu SY Kim, et al. 2006 Use of 3′-deoxy-3′-[18F] fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors Eur J Nucl Med Mol Imaging 33 412 419 1:CAS:528: DC%2BD28XjsFalurw%3D 10.1007/s00259-005-0011-4 16404598